Astellas Pharma China, Inc.

This study tested a drug called enfortumab vedotin in 40 Chinese patients with advanced bladder cancer that had already been treated with chemotherapy and immunotherapy. The goal was to see if the drug could shrink tumors and control the disease. The study measured how well the d…